Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (LMAT)
NASDAQ:LMAT
Holding LMAT?
Track your performance easily
LMAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$52.88 - $109.58
Previous Close$92.12
Volume455.20K
Average Volume (3M)151.56K
Market Cap
$2.07B
Enterprise Value$1.97B
Total Cash (Recent Filing)$123.89M
Total Debt (Recent Filing)$18.33M
Price to Earnings (P/E)50.5
Beta0.77
Next Earnings
Feb 20, 2025EPS Estimate
$0.49Last Dividend Ex-Date
Nov 21, 2024Dividend Yield0.69%
Share Statistics
EPS (TTM)1.82
Shares Outstanding22,484,021
10 Day Avg. Volume295,353
30 Day Avg. Volume151,557
Standard Deviation0.10
R-Squared0.25
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)6.26
Price to Sales (P/S)9.72
Price to Cash Flow (P/CF)36.40
P/FCF Ratio41.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.23
Enterprise Value/Gross Profit15.47
Enterprise Value/Ebitda39.28
Forecast
1Y Price Target
$97.83Price Target Upside6.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Lemaitre Vascular News
PremiumCompany Announcements
LeMaitre Vascular Prices $150M Convertible Notes Offering
PremiumCompany Announcements
LeMaitre Vascular to Offer $150M in Convertible Notes
PremiumCompany Announcements
LeMaitre Vascular Reports Strong Q3 2024 Growth
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
LMAT FAQ
What was Lemaitre Vascular’s price range in the past 12 months?
Lemaitre Vascular lowest stock price was $52.88 and its highest was $109.58 in the past 12 months.
What is Lemaitre Vascular’s market cap?
Currently, no data Available
When is Lemaitre Vascular’s upcoming earnings report date?
Lemaitre Vascular’s upcoming earnings report date is Feb 20, 2025 which is in 60 days.
How were Lemaitre Vascular’s earnings last quarter?
Lemaitre Vascular released its earnings results on Oct 31, 2024. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.435 by $0.055.
Is Lemaitre Vascular overvalued?
According to Wall Street analysts Lemaitre Vascular’s price is currently Undervalued.
Does Lemaitre Vascular pay dividends?
Lemaitre Vascular pays a Quarterly dividend of $0.159 which represents an annual dividend yield of 0.69%. See more information on Lemaitre Vascular dividends here
What is Lemaitre Vascular’s EPS estimate?
Lemaitre Vascular’s EPS estimate is $0.49.
How many shares outstanding does Lemaitre Vascular have?
Lemaitre Vascular has 22,484,020 shares outstanding.
What happened to Lemaitre Vascular’s price movement after its last earnings report?
Lemaitre Vascular reported an EPS of $0.49 in its last earnings report, beating expectations of $0.435. Following the earnings report the stock price went up 7.343%.
Which hedge fund is a major shareholder of Lemaitre Vascular?
Among the largest hedge funds holding Lemaitre Vascular’s share is Driehaus Capital Management LLC. It holds Lemaitre Vascular’s shares valued at 25M.
---
Lemaitre Vascular Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$97.83 (6.20% Upside)
$97.83 (6.20% Upside)
Blogger Sentiment
Bullish
LMAT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 10.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $552.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.29%
12-Months-Change
Fundamentals
Return on Equity
13.33%
Trailing 12-Months
Asset Growth
12.88%
Trailing 12-Months
Company Description
Lemaitre Vascular
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
---
LMAT Company Deck
---
LMAT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant sales and EPS growth, strong regional performance, and operational efficiency. However, there were challenges related to regulatory delays and filling sales rep positions. Despite these, the overall sentiment remains positive due to the substantial achievements in sales and margin improvements.Read More>---
LMAT Stock 12 Month Forecast
Average Price Target
$97.83
▲(6.20% Upside)
Technical Analysis
Best Analysts Covering LMAT
1 Year
1 Year Success Rate
19/32 ratings generated profit
1 Year Average Return
+21.48%
reiterated a buy rating 2 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 59.38% of your transactions generating a profit, with an average return of +21.48% per trade.
---